| Financial Year |
March 31 2023 |
| Monetary Funds |
247,641,139.77 |
| Held-for-trading Financial Assets |
3,000,000.00 |
| Notes Receivable |
79,950.00 |
| Accounts Receivable |
227,531,771.03 |
| Advances to Suppliers |
34,747,517.05 |
| Other Receivables |
23,187,978.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
133,851,579.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
71,813,031.10 |
| Other Current Assets |
14,051,666.60 |
| Total Current Assets |
757,845,672.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
6,655,354.57 |
| Long-term Equity Investment |
126,018,970.47 |
| Investment Properties |
-- |
| Fixed Assetes |
349,496,422.15 |
| Under-construction Projects |
33,871,713.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,593,912.72 |
| R&D expenses |
-- |
| Goodwill |
22,605,498.82 |
| Long-Term Deferred and Prepaid Expenses |
4,991,631.15 |
| Deferred Income Tax Assets |
52,688,056.48 |
| Other Non-Current Assets |
5,741,101.88 |
| Sub-Total of Non-Current Assets |
817,839,661.26 |
| Total Assets |
1,575,685,333.65 |
| Short-Term Loans |
416,195,459.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
97,216,650.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,487,330.05 |
| Taxes Payable |
7,661,206.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,838,960.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,209,583.70 |
| Other Current Liabilities |
3,256,041.25 |
| Sub-Total of Current Liabilities |
641,730,997.68 |
| Long-term Loans |
25,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,293,617.47 |
| Deferred Income Tax Liabilities |
4,395,105.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
99,171,551.43 |
| Total Liabilities |
740,902,549.11 |
| Paid-In Capital(Or Share Stock) |
309,187,315.00 |
| Capital Surplus |
399,054,232.43 |
| Surplus Reserve |
53,153,124.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
43,946,294.84 |
| Minority Stockholder's Interest |
36,798,487.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
797,984,297.23 |
| Owner's Equity（Stockholder's Equity） |
834,782,784.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,575,685,333.65 |
